BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34930164)

  • 1. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
    Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
    Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40-49 years: a modelling study.
    Huntley C; Torr B; Sud A; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet; 2023 Nov; 402 Suppl 1():S54. PubMed ID: 37997097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
    Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
    Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores for prediction of breast cancer in Korean women.
    Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
    Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
    Ho WK; Tan MM; Mavaddat N; Tai MC; Mariapun S; Li J; Ho PJ; Dennis J; Tyrer JP; Bolla MK; Michailidou K; Wang Q; Kang D; Choi JY; Jamaris S; Shu XO; Yoon SY; Park SK; Kim SW; Shen CY; Yu JC; Tan EY; Chan PMY; Muir K; Lophatananon A; Wu AH; Stram DO; Matsuo K; Ito H; Chan CW; Ngeow J; Yong WS; Lim SH; Lim GH; Kwong A; Chan TL; Tan SM; Seah J; John EM; Kurian AW; Koh WP; Khor CC; Iwasaki M; Yamaji T; Tan KMV; Tan KTB; Spinelli JJ; Aronson KJ; Hasan SN; Rahmat K; Vijayananthan A; Sim X; Pharoah PDP; Zheng W; Dunning AM; Simard J; van Dam RM; Yip CH; Taib NAM; Hartman M; Easton DF; Teo SH; Antoniou AC
    Nat Commun; 2020 Jul; 11(1):3833. PubMed ID: 32737321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
    Hou C; Xu B; Hao Y; Yang D; Song H; Li J
    BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
    Mavaddat N; Michailidou K; Dennis J; Lush M; Fachal L; Lee A; Tyrer JP; Chen TH; Wang Q; Bolla MK; Yang X; Adank MA; Ahearn T; Aittomäki K; Allen J; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Auer PL; Auvinen P; Barrdahl M; Beane Freeman LE; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Brenner H; Brentnall A; Brock IW; Brooks-Wilson A; Brucker SY; Brüning T; Burwinkel B; Campa D; Carter BD; Castelao JE; Chanock SJ; Chlebowski R; Christiansen H; Clarke CL; Collée JM; Cordina-Duverger E; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dumont M; Durcan L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Försti A; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Gilyazova IR; Glendon G; Goldberg MS; Goldgar DE; González-Neira A; Grenaker Alnæs GI; Grip M; Gronwald J; Grundy A; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hankinson SE; Harkness EF; Hart SN; He W; Hein A; Heyworth J; Hillemanns P; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Jakimovska M; Jakubowska A; Janni W; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kaczmarek K; Kataja V; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Knight JA; Ko YD; Kosma VM; Koutros S; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Lilyquist J; Lindblom A; Lindström S; Lissowska J; Lo WY; Loibl S; Long J; Lubiński J; Lux MP; MacInnis RJ; Maishman T; Makalic E; Maleva Kostovska I; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Martinez ME; Mavroudis D; McLean C; Meindl A; Menon U; Middha P; Miller N; Moreno F; Mulligan AM; Mulot C; Muñoz-Garzon VM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; Offit K; Olson JE; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Peto J; Pinchev M; Plaseska-Karanfilska D; Polley EC; Prentice R; Presneau N; Prokofyeva D; Purrington K; Pylkäs K; Rack B; Radice P; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Robson M; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seynaeve C; Shah M; Sherman ME; Shrubsole MJ; Shu XO; Slager S; Smeets A; Sohn C; Soucy P; Southey MC; Spinelli JJ; Stegmaier C; Stone J; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Truong T; Tzardi M; Ulmer HU; Untch M; Vachon CM; van Veen EM; Vijai J; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett W; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zhang Y; Zheng W; Ziogas A; ; ; ; Dunning AM; Thompson DJ; Chenevix-Trench G; Chang-Claude J; Schmidt MK; Hall P; Milne RL; Pharoah PDP; Antoniou AC; Chatterjee N; Kraft P; García-Closas M; Simard J; Easton DF
    Am J Hum Genet; 2019 Jan; 104(1):21-34. PubMed ID: 30554720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
    Mosley JD; Gupta DK; Tan J; Yao J; Wells QS; Shaffer CM; Kundu S; Robinson-Cohen C; Psaty BM; Rich SS; Post WS; Guo X; Rotter JI; Roden DM; Gerszten RE; Wang TJ
    JAMA; 2020 Feb; 323(7):627-635. PubMed ID: 32068817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of breast cancer risk based on profiling with common genetic variants.
    Mavaddat N; Pharoah PD; Michailidou K; Tyrer J; Brook MN; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Luben R; Brown J; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Czene K; Darabi H; Eriksson M; Peto J; Dos-Santos-Silva I; Dudbridge F; Johnson N; Schmidt MK; Broeks A; Verhoef S; Rutgers EJ; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Figueroa J; Chanock SJ; Brinton L; Lissowska J; Couch FJ; Olson JE; Vachon C; Pankratz VS; Lambrechts D; Wildiers H; Van Ongeval C; van Limbergen E; Kristensen V; Grenaker Alnæs G; Nord S; Borresen-Dale AL; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Trentham-Dietz A; Newcomb P; Titus L; Egan KM; Hunter DJ; Lindstrom S; Tamimi RM; Kraft P; Rahman N; Turnbull C; Renwick A; Seal S; Li J; Liu J; Humphreys K; Benitez J; Pilar Zamora M; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Bogdanova NV; Antonenkova NN; Dörk T; Anton-Culver H; Neuhausen SL; Ziogas A; Bernstein L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Cox A; Cross SS; Reed MW; Khusnutdinova E; Bermisheva M; Prokofyeva D; Takhirova Z; Meindl A; Schmutzler RK; Sutter C; Yang R; Schürmann P; Bremer M; Christiansen H; Park-Simon TW; Hillemanns P; Guénel P; Truong T; Menegaux F; Sanchez M; Radice P; Peterlongo P; Manoukian S; Pensotti V; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Brauch H; Brüning T; Ko YD; Sigurdson AJ; Doody MM; Hamann U; Torres D; Ulmer HU; Försti A; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Glendon G; Marie Mulligan A; Chenevix-Trench G; Balleine R; Giles GG; Milne RL; McLean C; Lindblom A; Margolin S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Eilber U; Wang-Gohrke S; Hooning MJ; Hollestelle A; van den Ouweland AM; Koppert LB; Carpenter J; Clarke C; Scott R; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Brenner H; Arndt V; Stegmaier C; Karina Dieffenbach A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Offit K; Vijai J; Robson M; Rau-Murthy R; Dwek M; Swann R; Annie Perkins K; Goldberg MS; Labrèche F; Dumont M; Eccles DM; Tapper WJ; Rafiq S; John EM; Whittemore AS; Slager S; Yannoukakos D; Toland AE; Yao S; Zheng W; Halverson SL; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Simard J; Hall P; Easton DF; Garcia-Closas M
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
    Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
    J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.